The Patients Before Monopolies Act, introduced in both the House and Senate, gives parent companies of PBMs three years to divest from pharmacies or face penalties.
Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.
Last Christmas, Anna Jaques Hospital in Massachusetts suffered a ransomware attack. Now, nearly a year later, it confirms hackers stole personal information on 316,342 patients.
The Federal Trade Commission did not accuse the companies of wrongdoing. However, it advised them to stay out of trouble by not deploying robocalls, impersonating the government or other common illegal marketing strategies.
California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue.
The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans.
